Search - tctmd.com

Displaying 41 - 60 of 98

Sort: Relevancy | Date

News Daily News

FDA: All Restrictions on Paclitaxel Devices for PAD Are Removed

L.A. McKeown

July 11, 2023

News Conference News LINC 2023

PROSPECT MONSTER: Real-World Data Confirm Low-Dose DCB Efficacy in PAD

L.A. McKeown

June 21, 2023

News Conference News SCAI 2023

Real-World CLTI Patients, Outcomes Are a Departure From BEST-CLI

L.A. McKeown

May 24, 2023

News Daily News

BASIL-2 Supports Endo-First Strategy for CLTI With Infrapopliteal Disease

L.A. McKeown

May 01, 2023

News Daily News

SAFE-AAA Flags Ongoing EVAR Device Risk and Urges More Surveillance

L.A. McKeown

March 16, 2023

News Conference News ISET 2023

BEST-CLI: Experts at ISET Look to Bridge Research Results and Practice

Caitlin E. Cox

January 25, 2023

News Daily News

REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD

L.A. McKeown

January 24, 2023

News Features

Does BEST-CLI Settle the Surgery vs Endovascular Question for CLTI?

L.A. McKeown

December 02, 2022

News Conference News

Paclitaxel Safety Concerns Wane as Hope Emerges for Newer PAD Devices

L.A. McKeown

November 18, 2022

News Conference News VIVA 2022

TRANSCEND: Low-Dose DCB for PAD Still Looking Good at 2 Years

L.A. McKeown

November 03, 2022

Presentation TCT 2022

What Do the Clinical Trials Tell Us to Do in Intermediate-Risk PE?

Presenter: Eric Secemsky

September 19, 2022

News Conference News TCT 2022

FLASH: More Data to Support Mechanical Thrombectomy in PE

L.A. McKeown

September 18, 2022

Presentation TCT 2022

Have We Gotten to the Final Word on Paclitaxel Safety?

Presenter: Eric Secemsky

September 17, 2022

Presentation TCT 2022

Increasing Diversity in Peripheral Vascular Disease Research: The Elegance Registry

Presenter: Eric Secemsky

September 17, 2022

News Daily News

IVUS Useful in Many Peripheral Intervention Scenarios, Consensus Document

L.A. McKeown

August 05, 2022

News Conference News SCAI 2022

SAFE-PAD Provides More Long-term Safety Data for Paclitaxel

L.A. McKeown

May 22, 2022

News Daily News

PAD Significantly Ups Morbidity and Mortality in AMICS

L.A. McKeown

March 29, 2022

News Daily News

Routine IVUS in Peripheral Interventions Supported by Small RCT

L.A. McKeown

March 09, 2022

Presentation TCT 2021

Opportunities to Improve Outcomes: IVUS

Presenter: Eric Secemsky

November 06, 2021

Presentation TCT 2021

Have We Gotten to the Final Word on Paclitaxel Safety?

Presenter: Eric Secemsky

November 06, 2021

Advertisement

FDA: All Restrictions on Paclitaxel Devices for PAD Are Removed

PROSPECT MONSTER: Real-World Data Confirm Low-Dose DCB Efficacy in PAD

Real-World CLTI Patients, Outcomes Are a Departure From BEST-CLI

BASIL-2 Supports Endo-First Strategy for CLTI With Infrapopliteal Disease

SAFE-AAA Flags Ongoing EVAR Device Risk and Urges More Surveillance

BEST-CLI: Experts at ISET Look to Bridge Research Results and Practice

REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD

Does BEST-CLI Settle the Surgery vs Endovascular Question for CLTI?

Paclitaxel Safety Concerns Wane as Hope Emerges for Newer PAD Devices

TRANSCEND: Low-Dose DCB for PAD Still Looking Good at 2 Years

What Do the Clinical Trials Tell Us to Do in Intermediate-Risk PE?

FLASH: More Data to Support Mechanical Thrombectomy in PE

Have We Gotten to the Final Word on Paclitaxel Safety?

Increasing Diversity in Peripheral Vascular Disease Research: The Elegance Registry

IVUS Useful in Many Peripheral Intervention Scenarios, Consensus Document

SAFE-PAD Provides More Long-term Safety Data for Paclitaxel

PAD Significantly Ups Morbidity and Mortality in AMICS

Routine IVUS in Peripheral Interventions Supported by Small RCT

Opportunities to Improve Outcomes: IVUS

Have We Gotten to the Final Word on Paclitaxel Safety?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content